Project Quine aims to integrate biological data into world models; what should R&D teams look at?

First distinguish data coverage from research capability.

If a system can only place various data types on the same interface, user experience might improve; however, if it can also find unnoticed relationships between different modalities and provide traceable evidence, its research value may further emerge. Evaluation should separately record 'which data can be accessed' and 'what new judgments can be produced.'

Drug discovery requires passing through stages beyond models.

"Has the potential to accelerate drug discovery" is a directional judgment, not a verified result. A model proposing candidate targets or molecules is merely the starting point of the process; subsequent steps require experimental replication, toxicity and efficacy evaluation, and long-term development work. If public materials only display model metrics or demo cases, one cannot yet calculate how much time and cost has been saved based on this.

R&D teams are better served by finding complete case chains: what inputs form the system's hypotheses, how researchers decide on next experiments, what actual results were obtained, and whether failure cases are equally public. Viewing successes and failures together allows for judging whether it supplements researchers' thinking or merely reorganizes known information.

How to conduct a small-scale trial

If the project side opens available entry points, the team can select a small topic with reliable reference answers for blind testing. First fix the dataset, questions, time budget, and evaluation criteria, then compare against existing tools and manual processes. Record whether system suggestions are interpretable, whether they generate new testable hypotheses, how much time error verification takes, and ask domain researchers to independently judge their value.

Check results with a fixed input

When reading a research case, label each conclusion as model prediction, experimentally tested or still unverified, recording the experimental object, control and measurements. Cell-level candidate screening must not be rewritten as human efficacy or clinical availability. This evidence table is for reading research; no biological experiment, drug reproduction or personal treatment advice was provided here.